Arrowhead Research | ARWR - Ebit





Ebit Veränderung Datum
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
Merck USD 7.33B 6.49B 2026-09
Moderna USD 130M 945M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 5.14B 411M 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06